Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Mark Schlegel
An Investigational RNAi Therapeutic Targeting Factor XII (ALN-F12) for the Treatment of Hereditary Angioedema
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Related publications
F12-Related Hereditary Angioedema With Normal C1Inh
Therapeutic Trial in Hereditary Angioedema Type III: Icatibant
World Allergy Organization Journal
Immunology
Pulmonary
Allergy
Respiratory Medicine
Nanofiltered C1 Inhibitor Concentrate for Treatment of Hereditary Angioedema
New England Journal of Medicine
Medicine
The Hereditary Angioedema Syndromes
Journal of Clinical Investigation
Medicine
The Pathophysiology of Hereditary Angioedema
World Allergy Organization Journal
Immunology
Pulmonary
Allergy
Respiratory Medicine
Treatment of Hereditary Angioedema With Plasma-Derived C1 Inhibitor
Therapeutics and Clinical Risk Management
Impact of Patisiran, an RNAi Therapeutic, on Orthostatic Intolerance in Patients With Hereditary Transthyretin-Mediated Amyloidosis
Journal of Cardiac Failure
Cardiovascular Medicine
Cardiology
Socioeconomic Burden of Hereditary Angioedema: Results From the Hereditary Angioedema Burden of Illness Study in Europe
Orphanet Journal of Rare Diseases
Medicine
Genetics
Pharmacology
Hereditary Angioedema as a Metabolic Liver Disorder: Novel Therapeutic Options and Prospects for Cure
Frontiers in Immunology
Allergy
Immunology